Viking Global Investors LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Viking Global Investors LP
CRD #132272
SEC #801-72433
CIK #0001103804
AUM 78.2 B (2026-06-15)
Employees 274 (28% Investors, 0% Brokers)
Phone203-863-5000
Address600 Washington Boulevard
Stamford, CT 06901-6000
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($B)
806448321602010201520212027
In the News
Fri, 24 Jul 2026 Viking Global Investors admits sitting out AI rally was a costly mistake — Crypto Briefing
Fri, 12 Jun 2026 Viking Global Investors Enters Voting Pact at Standard BioTools with 15.0% Stake — TradingView
Mon, 30 Mar 2026 Valstone Welcomes Viking Global Investors as First Institutional Minority Investor — PR Newswire Canada
Sector Form 13F Holdings Value ($B)
Visa Inc 1.9
Taiwan Semiconductor Manufacturing Co Ltd 1.5
Schwab Charles Corp 1.4
Walt Disney Co 1.3
Fortive Corp 1.2
Air Products & Chemicals Inc /DE/ 1.2
McDonalds Corp 1.1
Sherwin Williams Co 1.0
Tesla Motors Inc 0.9
Apple Inc 0.9
View All
Holdings by Sector ($B)
40322416802011201620212027
Type Form D Funds Date Sold AUM
PE Viking Global Opportunities Vintage IV Offshore LP [2026-03-31] 196.7 M
Filed 2025-09-30 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Commission $100,000 · Revenue Decline to Disclose
PE Viking Global Opportunities Vintage IV Onshore LP [2026-03-31] 1.1 B
Filed 2025-09-30 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Commission $2,100,000 · Revenue Decline to Disclose
PE Viking Partners Opportunities Fund LP 2026-03-31 3.5 B
PE Viking Structured Capital Offshore 2 Intermediate LP 2024-03-28 187.1 M
PE Viking Structured Capital Offshore LP [2023-03-31] 170.5 M 115.5 M
Filed 2023-10-06 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE Viking Structured Capital Onshore LP [2023-03-31] 165.0 M 386.7 M
Filed 2023-10-06 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE Viking Structured Capital Sidecar Offshore 2 LP 2023-03-31 140.7 M
PE Viking Structured Capital Sidecar Offshore LP [2023-03-31] 120.0 M 122.7 M
Filed 2023-10-06 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE Viking Structured Capital Sidecar Onshore LP [2023-03-31] 10.0 M 10.1 M
Filed 2023-10-06 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE Viking Global Opportunities Drawdown Offshore LP [2022-03-31] 699.1 M
Filed 2021-09-30 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
View All
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 21 78.2
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 21 78.2
By Discretionary
Discretionary 21 78.2
Non-Discretionary 0 0.0
Total 21 78.2
By Non-United States Persons
Non-United States Persons 53.5
United States Persons 24.7
Total 21 78.2
Limited Partners2011 - 2026
Houston Police Officers' Pension System
New York State and Local Retirement System
Form D Directors Role # Filings # Firms 2011 - 2026
Martin Lang Director 161 31
Brian Smith Director 204 6
Seth Lawry Director 17 4
Daniel Sundheim Executive Officer 47 3
Thomas Purcell Executive Officer 21 2
Viking Global Investors LP Promoter 21 2
David Ott Executive Officer 21 2
O Halvorsen Executive Officer 21 2
Rose Shabet Executive Officer 20 2
Viking Global Performance LLC Executive Officer 7 2
View All
EDGAR Form CIK 2011 - 2026
13F-HR [0001103804]
3 [0001103804]
4 [0001103804]
SC 13D [0001103804]
SC 13G [0001103804]
Form 13D/13G Filer Form 13D/13G Subject Filed
Viking Global Investors LP Standard Biotools Inc [2026-06-12]
Viking Global Investors LP Artiva Biotherapeutics Inc [2026-05-18]
Viking Global Investors LP Altimmune Inc [2026-05-01]
Viking Global Investors LP Lennox International Inc [2026-04-22]
Viking Global Investors LP Veradermics Inc [2026-02-12]
Viking Global Investors LP Regal Rexnord Corp [2026-01-13]
Viking Global Investors LP Chewy Inc [2025-12-30]
Viking Global Investors LP Pepgen Inc [2025-10-03]
Viking Global Investors LP Fortive Corp [2025-07-24]
Viking Global Investors LP Primo Brands Corp [2025-06-18]
Viking Global Investors LP Acuren Corp [2025-05-15]
Viking Global Investors LP Regal Rexnord Corp [2025-04-18]
Viking Global Investors LP Sionna Therapeutics Inc [2025-02-14]
Viking Global Investors LP BioMarin Pharmaceutical Inc [2024-09-30]
Viking Global Investors LP Longboard Pharmaceuticals Inc [2024-07-15]
Viking Global Investors LP Inhibrx Biosciences Inc [2024-06-07]
Viking Global Investors LP Oric Pharmaceuticals Inc [2024-01-30]
Viking Global Investors LP Standard Biotools Inc [2024-01-09]
Viking Global Investors LP Viking Therapeutics Inc [2023-11-02]
Viking Global Investors LP Standard Biotools Inc [2023-10-16]
Viking Global Investors LP Five9 Inc [2023-10-06]
Viking Global Investors LP Rayzebio Inc [2023-09-21]
Viking Global Investors LP Valvoline Inc [2023-08-24]
Viking Global Investors LP Newamsterdam Pharma Co NV [2023-06-20]
Viking Global Investors LP Verastem Inc [2023-06-05]
Viking Global Investors LP Frazier Lifesciences Acquisition Corp [2022-11-03]
Viking Global Investors LP Frazier Lifesciences Acquisition Corp [2022-11-02]
Viking Global Investors LP Trevi Therapeutics Inc [2022-10-07]
Viking Global Investors LP Cazoo Group Ltd [2022-09-19]
Viking Global Investors LP Ginkgo Bioworks Holdings Inc [2022-07-01]
Viking Global Investors LP Celldex Therapeutics Inc [2022-06-10]
Viking Global Investors LP Pepgen Inc [2022-05-20]
Viking Global Investors LP Standard Biotools Inc [2022-04-14]
Viking Global Investors LP Roivant Sciences Ltd [2022-02-14]
Viking Global Investors LP Amylyx Pharmaceuticals Inc [2022-01-21]
Viking Global Investors LP Guardant Health Inc [2022-01-18]
Viking Global Investors LP TDCX Inc [2021-10-15]
Viking Global Investors LP Procept Biorobotics Corp [2021-09-27]
Viking Global Investors LP Ginkgo Bioworks Holdings Inc [2021-09-27]
Viking Global Investors LP Rallybio Corp [2021-08-09]
Viking Global Investors LP Coupa Software Inc [2021-07-20]
Viking Global Investors LP API Group Corp [2021-06-16]
Viking Global Investors LP FIGS Inc [2021-06-07]
Viking Global Investors LP Talaris Therapeutics Inc [2021-05-17]
Viking Global Investors LP Mudrick Capital Acquisition Corp II [2021-04-16]
Viking Global Investors LP Edgewise Therapeutics Inc [2021-04-05]
Viking Global Investors LP Orion Acquisition Corp [2021-03-12]
Viking Global Investors LP Pharvaris NV [2021-02-16]
Viking Global Investors LP 4D Molecular Therapeutics Inc [2020-12-21]
Viking Global Investors LP Abcellera Biologics Inc [2020-12-21]
Viking Global Investors LP PMV Pharmaceuticals Inc [2020-10-05]
Viking Global Investors LP Athira Pharma Inc [2020-09-28]
Viking Global Investors LP Inhibrx Inc [2020-08-31]
Viking Global Investors LP Vertex Inc [2020-08-10]
Viking Global Investors LP Nuance Communications Inc [2020-08-10]
Viking Global Investors LP Gohealth Inc [2020-07-27]
Viking Global Investors LP Zentalis Pharmaceuticals Inc [2020-04-15]
Viking Global Investors LP Change Healthcare Inc [2020-03-10]
Viking Global Investors LP Adaptive Biotechnologies Corp [2020-02-11]
Viking Global Investors LP Canada Goose Holdings Inc [2020-01-21]
Viking Global Investors LP Chewy Inc [2019-12-12]
Viking Global Investors LP Bridgebio Pharma Inc [2019-07-08]
Viking Global Investors LP Myovant Sciences Ltd [2019-06-14]
Viking Global Investors LP Moderna Inc [2018-12-21]
Viking Global Investors LP Berry Global Group Inc [2018-10-22]
Viking Global Investors LP Urovant Sciences Ltd [2018-10-10]
Viking Global Investors LP Eidos Therapeutics Inc [2018-07-02]
Viking Global Investors LP Middleby Corp [2018-06-25]
Viking Global Investors LP United States Steel Corp [2018-03-09]
Viking Global Investors LP Jianpu Technology Inc [2017-11-30]
Viking Global Investors LP Parsley Energy Inc [2017-10-26]
Viking Global Investors LP Deciphera Pharmaceuticals Inc [2017-10-11]
Viking Global Investors LP Abeona Therapeutics Inc [2017-10-02]
Viking Global Investors LP ATYR Pharma Inc [2017-09-11]
Viking Global Investors LP Gulfport Energy Corp [2017-03-20]
Viking Global Investors LP Calithera Biosciences Inc [2017-02-21]
Viking Global Investors LP Myovant Sciences Ltd [2017-02-10]
Viking Global Investors LP Axovant Sciences Ltd [2016-07-13]
Viking Global Investors LP Arbutus Biopharma Corp [2016-07-13]
Viking Global Investors LP Calpine Corp [2016-07-05]
Viking Global Investors LP Dynegy Inc [2016-05-13]
Viking Global Investors LP Rice Energy Inc [2016-04-25]
Viking Global Investors LP Kite Pharma Inc [2016-02-29]
Viking Global Investors LP First Data Corp [2016-02-16]
Viking Global Investors LP Editas Medicine Inc [2016-02-09]
Viking Global Investors LP Encana Corp [2016-02-01]
Viking Global Investors LP Gulfport Energy Corp [2016-01-29]
Viking Global Investors LP Range Resources Corp [2016-01-25]
Viking Global Investors LP Cabot Oil & Gas Corp [2016-01-21]
Viking Global Investors LP Southwestern Energy Co [2016-01-21]
Viking Global Investors LP Broadcom Corp [2015-11-09]
Viking Global Investors LP Pioneer Natural Resources Co [2015-10-30]
Viking Global Investors LP Laboratory Corp of America Holdings [2015-10-13]
Viking Global Investors LP Kite Pharma Inc [2015-10-05]
Viking Global Investors LP Mallinckrodt PLC [2015-08-31]
Viking Global Investors LP Qunar Cayman Islands Ltd [2015-07-17]
Viking Global Investors LP Ctrip Com International Ltd [2015-07-17]
Viking Global Investors LP Whiting Petroleum Corp [2015-07-13]
Viking Global Investors LP Esperion Therapeutics Inc [2015-06-29]
Viking Global Investors LP AVIS Budget Group Inc [2015-05-15]
Viking Global Investors LP Envision Healthcare Holdings Inc [2015-04-20]
Viking Global Investors LP Sealed Air Corp/DE [2015-02-17]
Viking Global Investors LP Kansas City Southern [2015-02-05]
Viking Global Investors LP Cheniere Energy Inc [2015-02-05]
Viking Global Investors LP AVIS Budget Group Inc [2014-12-29]
Viking Global Investors LP Pioneer Natural Resources Co [2014-10-24]
Viking Global Investors LP Wayfair Inc [2014-10-14]
Viking Global Investors LP Salix Pharmaceuticals Ltd [2014-08-14]
Viking Global Investors LP Newfield Exploration Co /DE/ [2014-08-07]
Viking Global Investors LP Mohawk Industries Inc [2014-05-15]
Viking Global Investors LP Acadia Pharmaceuticals Inc [2014-05-05]
Viking Global Investors LP Illumina Inc [2014-03-10]
Viking Global Investors LP Triumph Group Inc [2013-08-30]
Viking Global Investors LP Cemex SAB de CV [2013-05-31]
Viking Global Investors LP Intuitive Surgical Inc [2013-05-20]
Viking Global Investors LP Michael KORS Holdings Ltd [2013-02-19]
Viking Global Investors LP Medivation Inc [2012-08-20]
Viking Global Investors LP Carters Inc [2012-03-30]
Viking Global Investors LP TripAdvisor Inc [2012-02-02]
Firm Profile (Form ADV)
Discretionary AUM$39.9B
ServesInstitutional
Fund TypesHedge Fund, Private Equity
LEIDYNXLZTYODOIILGV2H13
Form 3/4/5 Subject 2011 - 2026
Viking Global Opportunities GP LLC
Viking Global Investors LP
Viking Global Opportunities Illiquid Investments Sub-Master
Viking Global Opportunities Parent GP LLC
Viking Global Opportunities Portfolio GP LLC
Halvorsen Ole Andreas
Shabet Rose Sharon
Inhibrx Biosciences Inc
Ott David C
BridgeBio Pharma LLC
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Inhibrx Biosciences Inc INBX
Common Stock
2025-10-07 Sell 25,042 $32.25 807,604
Inhibrx Biosciences Inc INBX
Common Stock
2025-10-07 Sell 16,315 $32.25 526,159
Inhibrx Biosciences Inc INBX
Common Stock
2025-10-07 Sell 308,643 $32.25 9,953,737
BridgeBio Pharma LLC BBIO
Common Stock
2025-06-27 Sell 3,500,000 $44.00 154,000,000
BridgeBio Pharma LLC BBIO
Common Stock
2025-01-31 Sell 3,065,616 $34.90 106,989,998
APi Group Corp APG
Common Stock
2024-06-17 Sell 1,912,750 $38.15 72,971,412
APi Group Corp APG
Common Stock
2024-06-17 Sell 39,032 $38.15 1,489,071
APi Group Corp APG
Common Stock
2024-06-17 Sell 39,032 $38.15 1,489,071
APi Group Corp APG
Common Stock
2024-06-17 Sell 1,912,750 $38.15 72,971,412
Inhibrx Inc INBX
Common Stock
2024-05-30 Other 333,333 $30.00 9,999,990
Inhibrx Inc INBX
Common Stock
2024-05-30 Other 6,305,866 $30.00 189,175,980
Inhibrx Inc INBX
Common Stock
2024-05-30 Other 511,627 $30.00 15,348,810
Inhibrx Inc INBX
Warrants (right to buy) · derivative
2024-05-30 Other 1,038,765 $30.00 31,162,950
APi Group Corp APG
Common Stock
2024-03-05 Sell 60,772 $34.25 2,081,441
APi Group Corp APG
Common Stock
2024-03-05 Sell 2,977,845 $34.25 101,991,191
APi Group Corp APG
Common Stock
2024-03-05 Sell 2,977,845 $34.25 101,991,191
APi Group Corp APG
Common Stock
2024-03-05 Sell 60,772 $34.25 2,081,441
APi Group Corp APG
5.5% Series B Perpetual Convertible Preferred Stock · derivative
2024-02-28 Conversion 196,000 $0.00
APi Group Corp APG
Common Stock
2024-02-28 Conversion 8,036,862 $24.60 197,706,805
APi Group Corp APG
Common Stock
2024-02-28 Conversion 164,016 $24.60 4,034,794
showing 20 of 200 most recent transactions
Comparable Firms State AUM
Wellington Alternative Investments LLC
MA 92.2 B
Aegon USA Investment Management LLC
IA 88.8 B
Leonard Green & Partners LP
CA 85.6 B
Clearlake Capital Group LP
CA 83.6 B
Sequoia Capital Operations LLC
CA 82.2 B
Centerbridge Partners LP
NY 79.9 B
Tiger Global Management LLC
NY 78.0 B
Bain Capital Credit LP
MA 76.3 B
BlackRock Capital Investment Advisors LLC
DE 66.9 B
Blue Owl Credit Advisors LLC
NY 64.9 B
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com